Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II adaptive randomized double-blind placebo-controlled trial of intra-articular clodronate dose escalation in painful knee osteoarthritis
2021-003124-33Phase 2Active
- Sponsor
- Società Prodotti Antibiotici
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in knee osteoarthritis (OA) comparing Clodronate escalating-dose arm(s) with Placebo arm (2 arms). Primary endpoint: Knee pain VAS reduction at Week 7. Started Jan 2023; status: active.
02
Drugs
clodronate
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2021-003124-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-003124-33.